PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.434
https://www.valueinhealthjournal.com/article/S1098-3015(12)02147-X/fulltext
Title :
PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02147-X&doi=10.1016/j.jval.2012.08.434
First page :
A676
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
1969